SCHEMBL7657003

SCHEMBL7657003

CCNC1CCc2[nH]c3ccc(NC(=O)c4ccccc4C)cc3c2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 1/20 0.48
HTR1A P08908 2/20 0.47
HTR1B P28222 2/20 0.47
HTR1D P28221 1/20 0.47
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
CASP1 P29466 1/20 0.46
KMT2A Q03164 1/20 0.46
F2R P25116 2/20 0.44
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
HTR1E P28566 1/20 0.44
HTR7 P34969 1/20 0.44
OPRM1 P35372 1/20 0.44
TMEM97 Q5BJF2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7658867 0.91 HTR1F (0.51) HTR1FHTR1AHTR1BHTR1DSMN1; SMN2
SCHEMBL7663031 0.91 JAK2 (0.49) HTR1FHTR1AHTR1BHTR1DALDH1A1
SCHEMBL7654364 0.90 MEN1 (0.46) HTR1FHTR1AHTR1BHTR1DMEN1
SCHEMBL8116691 0.89 HTR1F (0.45) HTR1FHTR1AHTR1BHTR1DALDH1A1
SCHEMBL7656443 0.89 HTR1F (0.47) HTR1FHTR1AHTR1BHTR1DSMN1; SMN2
SCHEMBL7656407 0.88 HTR1F (0.56) HTR1FHTR1AHTR1BHTR1DALDH1A1
SCHEMBL7660703 0.87 HTR1F (0.49) HTR1FHTR1AHTR1BHTR1DALDH1A1
SCHEMBL7655587 0.87 JAK2 (0.51) HTR1FHTR1AHTR1BHTR1DALDH1A1
SCHEMBL7659496 0.86 HTR1A (0.48) HTR1FHTR1AHTR1BHTR1DMEN1
SCHEMBL7655204 0.86 ALDH1A1 (0.44) HTR1FHTR1AHTR1BHTR1DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0749962-B1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed